Names:

  • Lazarus Virus (used by the media)
  • CRCV (Cancer Re-growth Cell Vaccine, term used in scientific communities, has a span of virus types, much like the flu, categorized by numbers 1 through 20. CRCV-15 seems to be the active strain)
  • RAV (Reanimate and Attack Virus, used by most civilians and as a slang term for the infected. aka RAV positive.)

 

Overview

Here is a brief overview of the symptoms of the virus. Please read the entire article for in depth details.

  1. Infection occurs through a bite, scratch, exchange of bodily fluids or contact with infected blood or saliva with the eyes, nose, or mouth. The entire process can take a few hours to a few weeks.
  2. Symptoms start within minutes or hours depending on overall health of the person and their bodies natural virus defending capabilities.
    1. Body Aches, Fever, Cold Sweats
    2. Nausea, headache, fatigue
    3. Flesh eating rash discovered near site of infection in cases of bites and scratches.
    4. Seizures, high blood pressure, unconscious/comatose condition
  3. Once these symptoms exhibit, the following status of the infected can vary. Conditions include the following:
    1. Hallucinations
    2. Dementia
    3. Yellowish/Green drool or secretions from mucous glands in eyes and mouth
  4. Clinical death of a patient can occur within minutes to days of the final stage. It is unclear what dictates the speed at this time.
  5. Reanimation varies from patient to patient, also dependent on the severity of the injury. However, all documented cases show that no more than 6 hours pass from “death” to “reanimation”.
    1. Once reanimated patients become altered and tend to not respond to verbal commands or communication.
    2. They become aggressive and attack all living things around them including animals while they ignore most other infected humans
    3. They do not respond to pain of any kind.
  6. The only way to stop a reanimated body is to remove the head from the body or destroy the brain. Burning is not reccomended as often the flame is not hot enough to complete destroy the tissue and the zombie will continue to attack even if a weakened state.

 

History:

The world, in all its knowledge and advancements still couldn’t cure the common cold. However, this didn’t stop them from researching and experimenting, all in the efforts to find that key to unlock the mysterious world of disease and stop it in its tracks. At the top of this list were the more deadly viruses, cancer being one of the most highly funded yet difficult to decipher of them all. A small research facility, known simply as Cancer Research Inc (CRI) was founded by a wealthy philanthropist who poured millions of dollars into its work on finding a cure for the elusive and devastating disease.

 

It is unknown how they happened to begin viral therapy research into CRCV, the Cancer Re-growth Cell Vaccine, or how it was created in the first place. Many rumors have been cultivated, but there has never been a clear answer as to how it was made. However, after one small article was printed in a scientific journal, the community began to take note. Within a few years, as more information began to be released, the interest in sharing this new therapy with the world began to grow. Eventually, without much media fanfare, a single vial of the serum was sent out to several major research facilities all over the world.

 

Within months these labs were jockeying for more material. CRI was promised everything they could hope for to send out another vial, including copious amounts of money and equipment for their own research. Even the government took notice and began its own research into the serum.  Soon CRCV was being sent out in larger volumes, while money poured into the lab.

 

The opportunity to be the first to crack this strange viral code was too much to pass up. Almost every developed country wanted to get it on the research and be the first to cure the diseases that plagued the world. It would be priceless to get to the finish line first. Within a few years of its release, funding for research into this product was at an all time high. Entire buildings were dedicated to investigation of the vaccine and there was much buzz in the medical and science worlds.

In less than a decade, CRI had been given approval to begin research on lab animals. With positive results filling up volumes, the world had no choice but to take notice and allow testing on even more animals in several different labs. Testing evolved from rats and rabbits to dogs, and apes, all with encouraging results. Things were happening at an alarming speed, with CRI leading the way. It soon became the consensus of the world at large, that everyone should share on the research so that they could get to the cure sooner rather than later.

 

One day, incredible news was reported from CRI. An infected ape had been cured of cancer and was even immune to the introduction of several other diseases. It was proclaimed a miracle as more and more news of the same types of results came from around the world.  CRI immediately began to petition for clinical trials on humans. It was protested with great energy from those opposed to this strange new treatment that seemed to be bringing dead cells back to life.

 

Finally the day arrived, one autumn day the year before the outbreak began.  A tremor of hope rippled across the world as the first approval for human clinical trials was approved, almost 5 years after the first animal was cured.  Human volunteers were weary and only a small group came forward at first. But as results proved promising with the initial strains that were tested, more and more people began to put themselves on what had become a long waiting list.

 

Early spring, year of the outbreak: CRCV-15 was introduced. It was only 2 days from the first global test when the side effects began to manifest. It was only a few hours later that the first infected person left the hospital and was never seen again. It was only one day before the infection had spread to the general population and the world, as we knew it, began to end.

 

Origin of outbreak:

Hospitals, medical clinics, research facilities all over the world excluding the areas considered “safe zones” (see corresponding section for more details). The first patients to receive the vaccine in strains 1 – 14 are called A Patients, Alpha Immune Carriers and Transfer Prototypes. There is no word on where these people might be, if they succumbed to the infection, or were killed in the panic. It is rumored they may have a certain resistance, but no tests have been conducted.

 

Remaining Strains:

There are 4 remaining untested strains: CRCV 16 – 20. There is no knowledge where the samples of these strains may be located and no idea what they might do if tested on humans. There are rumors that the UDF is trying to recreate the strains while others say the SMC has the strains and are using them as collateral. Even stranger is the story that the Presidents bunker containing every strain and an anti-viral serum that can cure the infection.

 

None of those stories can be confirmed.

The only confirmed organization with access to all of the strains is the SFA.

 

Contraction and Symptoms:

CRCV is contracted by direct contact with the contaminant and the blood stream. Its lifespan outside of its ideal environment (the human body, or within the serum in a vial) is approximately 3 minutes.

 

The serum itself is the most contagious. It can be transferred through the skin of injected patients and in the air where a vial with a broken seal is located. The administrative staff members who were responsible for carrying the virus out of the confines of the hospital wards are thought to have contracted the virus by touching the skin of patients who had been introduced to CRCV-15 or simply by breathing the air in the ward after the vaccine was administered.

 

However, it would seem that once a patient is infected as a secondary host, transfer through the skin and air is restricted. The virus takes on a more dependent nature, dying outside of the host body in a few minutes as mentioned above.  It cannot penetrate past the layers of skin cells and seems to only gain access through the bloodstream (in an open wound or via bite) or mucous glands (eyes, mouth). There is a hypothesis that the virus changes with each host, but there is no confirmation on this yet.

 

 

Symptoms of CRCV-15 start very much like the flu. Body aches, fever and cold sweats are followed by nausea, headache and fatigue. Within hours, a flesh eating rash is discovered near the site of the injection or infection and the patient may suffer seizures, high blood pressure, or a comatose state. These symptoms can be mistaken for something else and might be ignored. However, as the virus progresses, there are reports of hallucinations, dementia, and a strange yellow or green drool that begins to secrete from the saliva glands.  Once this occurs, there is only a short time before the patient dies. It can take a few hours to a few days for this final stage to be reached, depending on the size and general health of the patient before infection.

 

Reanimation occurs after a patient is declared clinically dead. The moment’s right after reanimation is undocumented at this time, as most people who are in close proximity with a CRCV victims become infected long before they can write anything down. However, it is known that once a patient achieves an “undead” or “zombie” state, they become aggressive, do not respond to pain or any other attempts to stop their progress, and will scratch, bite, and eat anything they can. This includes animals, though they tend to go after other humans more likely than not.

 

Several hypotheses about reanimation explain that it seems the virus is able to rebuild the cells of the brain and activate it. It is not clear how this is possible or what other bodily functions are still active, but it is clear that the heart ceases beating and the monsters do not need to breathe.

 

 Immunity

There is a small segment of the population with a natural immunity to the virus. This does not make them safe because they will retain an active strain in their blood stream and can host an open wound that will not heal at the point of infection. Research is ongoing with these individuals and more information will be distributed when it becomes available.